BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+4.43%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$956M
AUM Growth
+$956M
(+13%)
Cap. Flow
+$86.3M
Cap. Flow
% of AUM
9.03%
Top 10 Holdings %
Top 10 Hldgs %
34.18%
Holding
136
New
4
Increased
64
Reduced
26
Closed
5
Top Buys
| 1 |
Illumina
ILMN
|
$11M |
| 2 |
Align Technology
ALGN
|
$10.5M |
| 3 |
CELG
Celgene Corp
CELG
|
$10.3M |
| 4 |
Elevance Health
ELV
|
$9.07M |
| 5 |
Gilead Sciences
GILD
|
$7.35M |
Top Sells
| 1 |
Medtronic
MDT
|
$6.88M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$5.81M |
| 3 |
Cigna
CI
|
$5.21M |
| 4 |
Centene
CNC
|
$4.92M |
| 5 |
BCR
CR Bard Inc.
BCR
|
$4.66M |
Sector Composition
| 1 | Healthcare | 94.19% |
| 2 | Financials | 0.94% |
| 3 | Industrials | 0.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HRC
26
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $12.6M | 1.32% | 169,939 +65,436 | +63% | +$4.84M |
|
|
ALXN
27
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $12.1M | 1.26% | 86,000 -6,000 | -7% | -$842K |
|
28
Stryker
SYK
$150B
| $12M | 1.25% | 84,300 | – | – |
|
|
29
Centene
CNC
$14.3B
| $11.5M | 1.2% | 118,930 -50,880 | -30% | -$4.92M |
|
30
LivaNova
LIVN
$3.08B
| $11.1M | 1.16% | 158,069 +55,261 | +54% | +$3.87M |
|
31
Zimmer Biomet
ZBH
$21B
| $10.9M | 1.14% | 93,000 +5,000 | +6% | +$585K |
|
32
Becton Dickinson
BDX
$55.3B
| $10.8M | 1.13% | 55,000 +3,000 | +6% | +$588K |
|
33
Teva Pharmaceuticals
TEVA
$21.1B
| $10.2M | 1.07% | 581,940 +296,611 | +104% | +$5.22M |
|
34
Tenet Healthcare
THC
$16.3B
| $10.1M | 1.06% | 616,796 +288,290 | +88% | +$4.73M |
|
35
AbbVie
ABBV
$372B
| $9.13M | 0.96% | 102,777 -11,797 | -10% | -$1.05M |
|
36
Vertex Pharmaceuticals
VRTX
$100B
| $9.09M | 0.95% | 59,800 -8,600 | -13% | -$1.31M |
|
|
AET
37
DELISTED
Aetna Inc
AET
| $9.02M | 0.94% | 56,700 +4,900 | +9% | +$779K |
|
38
Integra LifeSciences
IART
$1.18B
| $8.93M | 0.93% | 176,850 +16,500 | +10% | +$833K |
|
|
39
Cigna
CI
$80.3B
| $8.91M | 0.93% | 47,650 -27,850 | -37% | -$5.21M |
|
|
40
Alnylam Pharmaceuticals
ALNY
$58.5B
| $8.88M | 0.93% | 75,593 -49,436 | -40% | -$5.81M |
|
|
MNK
41
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $8.6M | 0.9% | 229,983 +45,038 | +24% | +$1.68M |
|
42
Labcorp
LH
$23.1B
| $8.26M | 0.86% | 54,680 +3,310 | +6% | +$500K |
|
43
MacroGenics
MGNX
$112M
| $8.01M | 0.84% | 433,299 +116,881 | +37% | +$2.16M |
|
44
Humana
HUM
$36.5B
| $7.64M | 0.8% | 31,350 +4,850 | +18% | +$1.18M |
|
|
BCR
45
DELISTED
CR Bard Inc.
BCR
| $7.29M | 0.76% | 22,740 -14,550 | -39% | -$4.66M |
|
46
IQVIA
IQV
$32.4B
| $6.77M | 0.71% | 71,170 +4,650 | +7% | +$442K |
|
47
Ligand Pharmaceuticals
LGND
$3.15B
| $6.63M | 0.69% | 48,700 -14,700 | -23% | -$2M |
|
|
SHPG
48
DELISTED
Shire pic
SHPG
| $6.5M | 0.68% | 42,440 -11,445 | -21% | -$1.75M |
|
|
HZNP
49
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $6.17M | 0.65% | 486,463 +79,065 | +19% | +$1M |
|
50
Cooper Companies
COO
$13.4B
| $5.69M | 0.6% | 24,000 | – | – |
|